pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis India clinical programs — 341 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Novartis India projects
341 ClinicalTrials.gov programs sponsored by Novartis India.
Novartis India has 341 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Secukinumab s.c. injection
Novartis Pharmaceuticals
Autoimmunity, Inflammation
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
brinzolamide 1%/brimonidine 0.2% fixed combination
Novartis Pharmaceuticals
Glaucoma
1 trial -
dabrafenib
Novartis Pharmaceuticals
Melanoma
1 trial -
Blood draw for Lp(a)
Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
1 trial
Frequently asked questions
How many clinical projects does Novartis India have?
341 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.